白介素35(IL35)活性蛋白
Active Interleukin 35 (IL35)
- 編號APC008Mu01
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)8.2
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià)
- 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
IL-35, also known as Interleukin-35, is a heterodimeric cytokine composed of two subunits, p35 and Epstein-Barr virus-induced gene 3 (EBI3). It belongs to the IL-12 family of cytokines and is primarily associated with the regulation of immune responses. IL-35 is produced by regulatory T cells (Tregs) and has been implicated in the suppression of immune responses, playing a role in maintaining immune tolerance and preventing autoimmune diseases. It is also produced by B regulatory cells and can contribute to the suppression of immune reactions in certain contexts.Besides,Interleukin 23 Subunit Alpha (IL23a) has been identified as an interactor of IL-35, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant mouse IL-35 and recombinant human IL23a. Briefly, IL-35 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to IL23a-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-IL-35 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant mouse IL-35 and recombinant human IL23a was shown in Figure 1, the EC50?for this effect is 0.049ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPC008Mu02 | 白介素35(IL35)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APC008Mu01 | 白介素35(IL35)活性蛋白 | Cell?culture;?Activity?Assays. |
RPC008Mu01 | 白介素35(IL35)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC008Mu01 | 白介素35(IL35)多克隆抗體 | WB; IHC; ICC; IP. |
SEC008Mu | 白介素35(IL35)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
MEC008Mu | 白介素35(IL35)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCC008Mu | 白介素35(IL35)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMC008Mu | 白介素35(IL35)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Oncology Letters | Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia. [PubMed: 22783403] |
Journal of Maternal-Fetal and Neonatal Medicine | Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease [Pubmed: 24175856] |
Journal of Reproductive Immunology | What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? [Pubmed: 24368037] |
Human Immunology | The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia [ScienceDirect: S0198885913005776] |
Folia Biologica (Praha) | Gene Expression of Subunits of the IL-12 Family Cytokines in moDCs Derived In Vitro from the Cord Blood of Children of Healthy and Allergic Mothers [Pubmed:24785110] |
Molecular Medicine Reports | Function of interleukin?17 and ?35 in the blood of patients with hepatitis B?related liver cirrhosis [Pubmed:25323532] |
Rom J Morphol Embryol. | The regular distribution and expression pattern of immunosuppressive cytokine IL-35 in mouse uterus during early pregnancy [Pubmed:25611266] |
Journal of Immunotherapy | Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity [PubMed: 25962106] |
PLOS ONE | Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis [PubMed: 26204444] |
Rheumatology (Oxford) | Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease [PubMed: 26231346] |
Cytokine | Anti-inflammatory effects of interleukin-35 in acquired aplastic anemia [PubMed: 26282938] |
J Biol Chem | Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway [PubMed: 26085094] |
Br J Haematol | Interleukin 35 may contribute to the loss of immunological self‐tolerance in patients with primary immune thrombocytopenia [PubMed: 25640666] |
Autoimmunity Reviews | New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature [Pubmed:26876383] |
Clinical research | Increased plasma concentrations of interleukin 35 in patients with coronary artery disease [Journal:-19] |
Clinical?Rheumatology | The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis [pubmed:27502600] |
Respiratory?Medicine | Enhanced LPS-induced activation of IL-27 signalling in sarcoidosis [pubmed:27492538] |
International Journal of Molecular Medicine | Effects?of an?intravitreal?injection?of?interleukin-35-expressing?plasmid?on?pro-inflammatory?andanti-inflammatory?cytokines. [pubmed:27460435] |
上海口腔醫(yī)學(xué) | IL-35在牙周炎及口腔扁平苔蘚中的表達(dá)及相關(guān)性分析 [QK:98604X] |
Reproductive Sciences | Upregulation of Interleukin 35 in Patients With Endometriosis Stimulates Cell Proliferation [pubmed:28659009] |
EXPERIMENTAL AND THERAPEUTIC?MEDICINE | IL?35 may maintain homeostasis of the immune microenvironment in periodontitis [issn:2542-3975] |
The Journal of Rheumatology | Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis [pubmed:29247146] |
Cellular & Molecular Immunology | Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro [pubmed:28713164] |
Molecular?Medicine?Reports | Lower level of IL?35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test?positive hemocytopenia. [pubmed:29257310] |
Asian pacific journal of allergy and immunology | Evaluation of serum interleukin- 35 level in children with persistent asthma. [pubmed:27996283] |
PLoS One | Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio [pubmed:29236782] |
Hepatology Communications | Significant association between FOXP3 gene polymorphism and steroid-resistant acute rejection in living donor liver transplantation [10.1002/hep4.1052] |
International Journal of Clinical and Experimental Medicine | Clinical significance of IL-35 expression in the progression of clear cell renal cell carcinoma [ISSN:1940-5901] |
OncoTargets and Therapy | Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy. [pubmed:28761357] |
Annals of Rheumatic Diseases? | AB0734 Serum il-35 levels in systemic sclerosis and relationship with clinical features [10.1136:annrheumdis-2018-eular.2605] |
Tohoku?Journal of Experimental?Medicine | Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients [Pubmed:29576585] |
Turkish?Journal Of?Medical?Sciences | The impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility [Pubmed:29914245] |
Oncotarget | Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas [Pubmed:29721156] |
Journal of Clinical Rheumatology | Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features. [Pubmed: 30431486] |
Oncology Letters | Interleukin?35 is associated with the tumorigenesis and progression of prostate cancer [] |
Journal of Clinical Investigation | Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35 [Pubmed: 31264967] |
Cells | CD4+ FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired [Pubmed: 32111105] |
Cytokine | Interleukin-35 in idiopathic inflammatory myopathies [Pubmed: 33128920] |
FEBS Open Bio | IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1, and IGFBP1 [Pubmed: 33064893] |
Cancer Cell International | Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity [Pubmed: 33041668] |
Journal of Neuroinflammation | Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain [Pubmed: 32375811] |
Int Immunopharmacol | Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis [33307515] |
Archives of Medical Science | Decreased interleukin-35 levels and CD4+ EBI3+ T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) [33488880] |
Asia Pac Allergy | Anti-inflammatory roles of interleukin-35 in the pathogenesis of Japanese cedar pollinosis [34386410] |
Int Immunopharmacol | Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression [Pubmed:35247859] |
Biology and Medical Researches | Association of three single nucleotide polymorphisms of interleukin-35 for detection and prediction of women with breast cancer in Erbil city [] |
Research Square | Analysis of IL-10 and IL-35 in DPP-4 inhibitor-related bullous pemphigoid [] |